Now showing items 1-6 of 6

    • An external dosimetry audit programme to credential static and rotational IMRT delivery for clinical trials quality assurance. 

      Eaton, DJ; Tyler, J; Backshall, A; Bernstein, D; Carver, A; Gasnier, A; Henderson, J; Lee, J; Patel, R; Tsang, Y; Yang, H; Zotova, R; Wells, E (2017-03)
      Purpose External dosimetry audits give confidence in the safe and accurate delivery of radiotherapy. The RTTQA group have performed an on-site audit programme for trial recruiting centres, who have recently implemented ...
    • Clinical development of new drug-radiotherapy combinations. 

      Sharma, RA; Plummer, R; Stock, JK; Greenhalgh, TA; Ataman, O; Kelly, S; Clay, R; Adams, RA; Baird, RD; Billingham, L; Brown, SR; Buckland, S; Bulbeck, H; Chalmers, AJ; Clack, G; Cranston, AN; Damstrup, L; Ferraldeschi, R; Forster, MD; Golec, J; Hagan, RM; Hall, E; Hanauske, A-R; Harrington, KJ; Haswell, T; Hawkins, MA; Illidge, T; Jones, H; Kennedy, AS; McDonald, F; Melcher, T; O'Connor, JPB; Pollard, JR; Saunders, MP; Sebag-Montefiore, D; Smitt, M; Staffurth, J; Stratford, IJ; Wedge, SR; NCRI CTRad Academia-Pharma Joint Working Group (2016-10)
      In countries with the best cancer outcomes, approximately 60% of patients receive radiotherapy as part of their treatment, which is one of the most cost-effective cancer treatments. Notably, around 40% of cancer cures ...
    • Implementing diffusion-weighted MRI for body imaging in prospective multicentre trials: current considerations and future perspectives. 

      deSouza, NM; Winfield, JM; Waterton, JC; Weller, A; Papoutsaki, M-V; Doran, SJ; Collins, DJ; Fournier, L; Sullivan, D; Chenevert, T; Jackson, A; Boss, M; Trattnig, S; Liu, Y (2018-03)
      For body imaging, diffusion-weighted MRI may be used for tumour detection, staging, prognostic information, assessing response and follow-up. Disease detection and staging involve qualitative, subjective assessment of ...
    • Radiotherapy Quality Assurance for the CHHiP Trial: Conventional Versus Hypofractionated High-Dose Intensity-Modulated Radiotherapy in Prostate Cancer. 

      Naismith, O; Mayles, H; Bidmead, M; Clark, CH; Gulliford, S; Hassan, S; Khoo, V; Roberts, K; South, C; Hall, E; Dearnaley, D; CHHiP Investigators (2019-09)
      Aims The CHHiP trial investigated the use of moderate hypofractionation for the treatment of localised prostate cancer using intensity-modulated radiotherapy (IMRT). A radiotherapy quality assurance programme was developed ...
    • Realizing the potential of magnetic resonance image guided radiotherapy in gynaecological and rectal cancer. 

      White, IM; Scurr, E; Wetscherek, A; Brown, G; Sohaib, A; Nill, S; Oelfke, U; Dearnaley, D; Lalondrelle, S; Bhide, S (2019-06)
      CT-based radiotherapy workflow is limited by poor soft tissue definition in the pelvis and reliance on rigid registration methods. Current image-guided radiotherapy and adaptive radiotherapy models therefore have limited ...
    • The transformation of radiation oncology using real-time magnetic resonance guidance: A review. 

      Hall, WA; Paulson, ES; van der Heide, UA; Fuller, CD; Raaymakers, BW; Lagendijk, JJW; Li, XA; Jaffray, DA; Dawson, LA; Erickson, B; Verheij, M; Harrington, KJ; Sahgal, A; Lee, P; Parikh, PJ; Bassetti, MF; Robinson, CG; Minsky, BD; Choudhury, A; Tersteeg, RJHA; Schultz, CJ; MR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium
      Radiation therapy (RT) is an essential component of effective cancer care and is used across nearly all cancer types. The delivery of RT is becoming more precise through rapid advances in both computing and imaging. The ...